These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9239800)

  • 1. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.
    Sondel PM; Hank JA; Trigg ME; Kohler PC; Finlay JL; Blank J; Meisner L; Borcherding W; Hong R; Steeves R
    Exp Hematol; 1986 May; 14(4):278-86. PubMed ID: 3516715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency.
    Rosenkrantz K; Keever C; Bhimani K; Horvath A; Brochstein J; O'Reilly R; Dupont B; Flomenberg N
    J Immunol; 1990 Mar; 144(5):1721-8. PubMed ID: 2307837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
    Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One haplotype matched bone marrow grafts: an investigation using the HLA system as a marker of cellular origin.
    Jones EH; Lawler SD; Powles RL
    Dis Markers; 1988 Mar; 6(1):47-55. PubMed ID: 3293882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT).
    van Els C; Bakker A; Zwaan F; van Rood JJ; Goulmy E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2987-8. PubMed ID: 2468249
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic monitoring of bone marrow transplantation. Experience with 16 cases].
    Májský A; Soucek J; Herzog P; Korínková P; Prazák J
    Vnitr Lek; 1990 Apr; 36(4):318-23. PubMed ID: 2141442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
    Oudshoorn M; Cornelissen JJ; Fibbe WE; de Graeff-Meeder ER; Lie JL; Schreuder GM; Sintnicolaas K; Willemze R; Vossen JM; van Rood JJ
    Bone Marrow Transplant; 1997 Dec; 20(12):1011-7. PubMed ID: 9466272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
    Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
    Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
    Sugimoto K; Murata M; Terakura S; Naoe T
    J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation.
    Aviner S; Yao X; Krauthgamer R; Gan Y; Goren-Arbel R; Klein T; Tabilio A; McMannis JD; Champlin R; Martelli MF; Bachar-Lustig E; Reisner Y
    Hum Immunol; 2005 Jun; 66(6):644-52. PubMed ID: 15993710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
    Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
    Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes.
    Porubská S; Buc M; Bencová M; Sausová E
    Folia Biol (Praha); 1993; 39(5):256-61. PubMed ID: 8206171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pretransplant activity of cytotoxic T-lymphocytes in non-related bone marrow donor/recipient combinations with a perfect HLA match].
    Rufer N; Breur B; Tiercy JM; Speiser D; Chapuis B; Gratwohl A; Jeannet M; Roosnek E
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2257-8. PubMed ID: 8272799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.